Good news on drugs

A new drug combination could revolutionise the treatment of advanced PCa and give sufferers months of extra life. More here And NICE has approved darolutamide in combination with hormone therapy and chemotherapy for men with hormone-sensitive advanced PCa. It’s estimated around 6,000 men could benefit (Jun ’23). More here And researchers have found that targeting a single enzyme, called PI5P4Kα, can kill PCa cells, including those that have developed resistance to traditional treatments. More here